Healthcare Software / Real-World Data & Evidence (RWD/RWE)
Strategic Profile
With the Palantir-powered iRWD platform now live and fully searchable, OneMedNet is executing its strategy of securing high-margin, annual recurring revenue (ARR) subscriptions, with the Company believing the combination of the new platform capabilities and an expanding customer pipeline positions the Company to convert growing interest into meaningful revenue opportunities. OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 2,130 healthcare sites through its iRWD platform.
Cyborg Score Rationale
The company remains unprofitable, with net losses of $2.8 million in 2025 and $10.1 million in 2024 and an accumulated deficit of about $104.4 million, and its auditors raised substantial doubt about its ability to continue as a going concern. While the Palantir integration and 2025 de-leveraging are positive signals, the micro-cap stock trades near $1.17, early-stage monetization challenges, and going concern warnings indicate significant execution risk.
Top Insights
Recently launched AI-powered Palantir Foundry integration enabling conversational search on 80M+ patient journeys across 2,130+ healthcare sites—major technical inflection point for enterprise adoption
2025 showed 62% reduction in liabilities through equity raises and debt-for-equity conversions, signaling management's capital efficiency pivot and insider commitment to the business
Operates in high-growth RWD market for pharma, medtech, and AI companies, but facing intense competition and complex FDA/privacy compliance requirements limiting addressable customer base
Severe burn rate ($2.8M annual losses) and accumulated $104.4M deficit with only ~23 employees suggests runway challenges despite capital restructuring; survival dependent on revenue acceleration
Named Competitors
Flatiron Health — Oncology-focused real-world data platform
IQVIA RWD — Large diversified clinical research and real-world data provider
Veradigm — Health data and AI-powered analytics platform
Tempus — AI-driven real-world clinical data for precision oncology
Recent Developments
(April 2026) Launched Palantir Foundry-powered iRWD platform live with 80M patient journeys and conversational search capability enabling high-margin ARR subscriptions
(2025) Completed 62% liability reduction through equity placements ($4.2M net proceeds) and debt conversions; reported improving net losses to $2.8M from $10.1M in 2024
(November 2023) Completed SPAC business combination with Data Knights, began trading on NASDAQ under ticker ONMD
Open the full interactive OneMedNet Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.